Cognitive behavioral interventions for alcohol and drug use disorders: Through the stage model and back again.
Year: 2017
Type: review
Abstract: marks its 30th anniversary, we review the evolution of CBT for the addictions through the lens of the Stage Model of Behavioral Therapies Development. The large evidence base from Stage II randomized clinical trials indicates a modest effect size with evidence of relatively durable effects, but limited diffusion in clinical practice, as is the case for most empirically validated approaches for mental health and addictive disorders. Technology may provide a means for CBT interventions to circumvent the "implementation cliff" in Stages III-V by offering a flexible, low-cost, standardized means of disseminating CBT in a range of novel settings and populations. Moreover, returning to Stage I to reconnect clinical applications of CBT to recent developments in cognitive science and neuroscience holds great promise for accelerating understanding of mechanisms of action. It is critical that CBT not be considered as a static intervention, but rather 1 that constantly evolves and is refined through the stage model until the field achieves a maximally powerful intervention that addresses core features of the addictions. (PsycINFO Database Record
DOI: 10.1037/adb0000311
Authors: Kathleen M. Carroll, Brian D. Kiluk
Institution: Yale University
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Awards: Efficacy and Mechanisms of CBT4CBT for Alcohol Use Disorders, G2425941292, Computer-Based Training in Cognitve Behavioral Therapy, G3931357518, Psychotherapy Development Research Center, Neural mechanisms of CBT in cocaine dependence, Computer Based Training in CBT for Spanish-Speaking Substance Users, The National Drug Abuse Treatment Clinical Trials Network (U10), A Stage I Study of Computer Based Training in CBT for Alcohol Use Disorders, G7018901539, Computer-based Training in Cognitive Behavioral Therapy: Web-based delivery of CB, CTN New England Consortium Node, Yale Clinical and Translational Science Award
OpenAlex ID: W2752498244
